Skip to main content
. 2023 Nov 29;18:907. doi: 10.1186/s13018-023-04409-w

Table 1.

Demographic data and clinical information of participants

Variables Haemophilia A (n = 90)
Number (%)
Haemophilia B (n = 10)
Number (%t)
P value
Age at diagnosis (year)
 < 1 56 (62.2) 4 (50)
1–5 16 (17.7) 2 (25)
5–10 6 (6.6) 1 (12.5)
 > 10 12 (11.1) 1(12.5)
Current age (Y) mean (SD) 31.6 (14.4) 30.5 (20.6) 0.82
Severity of disease
Mild 16 (17.8) 1 (10) 0.027
Moderate 1 (1.1) 2 (20)
Severe 73 (81.1) 7 (70)
Inhibitor
No 88 (97.8) 10 (100)  < 0.999
Yes 2 (2.2) 0 (0)
Annual bleeding
1–3 19 (21.1) 4 (40) 0.306
4–6 21 (23.3) 3 (30)
7–12 45 (50) 2 (20)
 < 12 5 (5.6) 1 (10)
Treatment
Prophylaxis 14(15.6) 4(40) 0.077
On-demand 76(84.4) 6(60)
Number of joints involved
Single joint 6 (6.7) 1 (10) 0.481
Multiple joints 84 (93.3) 9 (90)
Target joint
Yes 39 (43.3) 0 (0) 0.006
No 51 (56.7) 10 (100)
Radiosynovectomy by 32P chromic phosphate
Yes 18 (20) 2 (20)  > 0.999
No 72 (80) 8 (80)
History of surgery
Yes 16 (17.8) 2 (20)  > 0.999
No 74 (82.2) 8 (80)
Fracture
Yes 6 (6.7) 0 (0)  > 0.999
No 84 (93.3) 10 (100)
Osteoporosis
Yes 35 (38.9) 4 (40)  > 0.999
No 55 (61.1) 6 (60)
Hepatitis C infection
Active
 Yes 14 (15.6) 0 (0) 0.349
 No 76 (84.4) 10 (100)
History
 Yes 26 (28.9) 0 (0) 0.060
 No 64 (71.1) 10 (100)
Osteoarthritis
Yes 59(65.6) 5(50) 0.489
No 31(34.4) 5(50)